Skip to main content

Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study.

Publication ,  Journal Article
Kereiakes, DJ; Feldman, RL; Ijsselmuiden, AJJ; Saito, S; Amoroso, G; Zidar, JP; Wong, SC; Stella, P; Yakubov, S; Lasala, J; Cohen, DJ; Rao, SV ...
Published in: Circ Cardiovasc Interv
September 2021

[Figure: see text].

Duke Scholars

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

September 2021

Volume

14

Issue

9

Start / End Page

e010609

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stents
  • Sirolimus
  • Prospective Studies
  • Polymers
  • Percutaneous Coronary Intervention
  • Humans
  • Everolimus
  • Drug-Eluting Stents
  • Coronary Artery Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kereiakes, D. J., Feldman, R. L., Ijsselmuiden, A. J. J., Saito, S., Amoroso, G., Zidar, J. P., … Rao, S. V. (2021). Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study. Circ Cardiovasc Interv, 14(9), e010609. https://doi.org/10.1161/CIRCINTERVENTIONS.121.010609
Kereiakes, Dean J., Robert L. Feldman, A. J. J. Ijsselmuiden, Shigeru Saito, Giovanni Amoroso, James P. Zidar, S Chiu Wong, et al. “Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study.Circ Cardiovasc Interv 14, no. 9 (September 2021): e010609. https://doi.org/10.1161/CIRCINTERVENTIONS.121.010609.
Kereiakes, Dean J., et al. “Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study.Circ Cardiovasc Interv, vol. 14, no. 9, Sept. 2021, p. e010609. Pubmed, doi:10.1161/CIRCINTERVENTIONS.121.010609.
Kereiakes DJ, Feldman RL, Ijsselmuiden AJJ, Saito S, Amoroso G, Zidar JP, Wong SC, Stella P, Yakubov S, Lasala J, Cohen DJ, Doros G, Cutlip DE, Rao SV. Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study. Circ Cardiovasc Interv. 2021 Sep;14(9):e010609.

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

September 2021

Volume

14

Issue

9

Start / End Page

e010609

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stents
  • Sirolimus
  • Prospective Studies
  • Polymers
  • Percutaneous Coronary Intervention
  • Humans
  • Everolimus
  • Drug-Eluting Stents
  • Coronary Artery Disease